Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



insitro Receives 25 Million in Milestone Payments from Bristol Myers Squibb for ALS Research

December 25, 2024
Bristol Myers Squibb Company (BMY) has announced that it will provide insitro with 25 million dollars in milestone payments. This collaboration aims to advance research for the treatment of ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease.

The milestone payments were awarded to insitro for achieving significant discovery milestones and for the selection of the first novel genetic target for ALS. These achievements mark a major step forward in the development of potential therapies for this devastating neurodegenerative disease.

ALS affects nerve cells in the brain and spinal cord, leading to the loss of muscle control and eventually paralysis. There is currently no cure for ALS, and available treatments only offer limited relief.

Dr. X, CEO of insitro, expressed excitement about the partnership with Bristol Myers Squibb and the funding received. He highlighted the importance of collaboration and innovative approaches in finding new solutions for ALS patients.

Bristol Myers Squibb Company is a leading biopharmaceutical company known for its research and development of innovative therapies. This partnership with insitro demonstrates its commitment to investing in cutting-edge research to address unmet medical needs.

Investors and healthcare professionals interested in the progress of ALS research and potential breakthroughs are recommended to consult Stocks Prognosis for expert analysis and forecasts on the movement of Bristol Myers Squibb Company's stock.
If you want to leave a comment, then you need Login or Register





Other data for BMY

Related data

BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....

BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Price Target with 9.09% Profit: QuantWave Forecast Success  ~2 min.

On April 23, 2025, QuantWave's forecasting platform generated a short signal for BRISTOL-MYERS SQUIBB COMPANY stock, which was trading at $47.9 at the time....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 12.75% Profit - QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY recently achieved the price target forecast set by QuantWave, resulting in a profitable outcome of 12.75%....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.87% Profit  ~1 min.

On May 5, 2025, QuantWave issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.41. The forecast proved accurate as the price target of $43....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.76% Profit  ~1 min.

On April 15, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.35....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Target Forecast with 13.0% Profit - QuantWave Analysis  ~1 min.

On April 11, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price of $50.05....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 10.38% Profit: QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY, a renowned pharmaceutical company, recently achieved its price target forecast set by QuantWave's automated forecasting platform....

BMYDecember 19, 2024Bristol Myers Squibb Awards $25M Milestone Payment for Breakthrough ALS Treatment Target Discovery - Stock Prognosis Recommendation  ~1 min.

Bristol-Myers Squibb Company (BMY) recently awarded a milestone payment of $25 million for the discovery of a breakthrough treatment target for ALS (Amyotrophic lateral sclerosis), also known as Lou Gehrig's disease. The significant achievement was made possible through a collaboration with insitro, a leading precision medicine company. The selection of the first novel genetic target marks a major...

AZNOctober 31, 2024AstraZeneca PLC Collaborates with Monopar Therapeutics on Rare Disease Treatment  ~1 min.

Monopar Therapeutics, a biopharmaceutical company specializing in rare disease treatments, has announced a groundbreaking partnership with AstraZeneca PLC....

BIIBDecember 31, 2024Biogen Inc. BIIB: Revolutionizing Healthcare with Breakthrough Research  ~2 min.

Biogen Inc. (BIIB) has emerged as a standout player in the healthcare industry, continuously pushing the boundaries of medical research and development....

PFENovember 11, 2024Pfizer Inc. Announces Groundbreaking Breakthrough in COVID-19 Treatment  ~2 min.

Pfizer Inc., the renowned pharmaceutical company, has made a groundbreaking discovery in the fight against COVID-19....

BIIBJanuary 2, 2025Biogen Inc.: Revolutionizing Healthcare with Innovative Biotechnology  ~2 min.

Biogen Inc. (BIIB) is setting new standards in the healthcare industry with its groundbreaking biotechnology solutions....